<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
NNVC
NanoViricides
$
()


  • NanoViricides plans to advance NV-387 into Phase II clinical trials

    9/30/2024 - 06:39am
  • NanoViricides says made 'significant progress' in NV-387 regulatory advancement

    9/30/2024 - 06:39am
  • NanoViricides files annual report on Form 10-K

    9/30/2024 - 06:37am
  • NanoViricides investigating MEURI protocol for using NV-387 to treat MPOX

    8/26/2024 - 07:42am
  • NanoViricides provides update on NV-387 pathway

    8/19/2024 - 07:11am
  • NanoViricides provides update on development program for NV-387

    7/11/2024 - 06:51am
  • NanoViricides provides update on current assets, technology platform

    7/1/2024 - 09:00am
  • Biotech Alert: Searches spiking for these stocks today

    6/13/2024 - 10:53am
  • Biotech Alert: Searches spiking for these stocks today

    6/12/2024 - 11:06am
  • NanoViricides engages Aagami to seek licensing, partnering opportunities

    5/23/2024 - 08:39am
  • Biotech Alert: Searches spiking for these stocks today

    5/10/2024 - 11:15am
  • Biotech Alert: Searches spiking for these stocks today

    5/9/2024 - 11:06am
  • NanoViricides says antiviral activity spectrum of NV-387 includes Influenza A

    5/6/2024 - 06:58am
dynamic_feed Breaking News